Publication: The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial
| dc.contributor.authors | Ozmen, V.; Ozbas, S.; Karanlik, H.; Muslumanoglu, M.; Igci, A.; Canturk, Z.; Utkan, Z.; Ozaslan, C.; Evrensel, T.; Uras, C.; Aksaz, E.; Soyder, A.; Ugurlu, U. M.; Col, C.; Cabioglu, N.; Bozkurt, B.; Uzunkoy, A.; Sezgin, E.; Gurleyik, G.; Soran, A. | |
| dc.date.accessioned | 2022-03-12T16:24:29Z | |
| dc.date.accessioned | 2026-01-11T19:15:39Z | |
| dc.date.available | 2022-03-12T16:24:29Z | |
| dc.date.issued | 2019 | |
| dc.identifier.doi | doiWOS:000491295501127 | |
| dc.identifier.eissn | 1569-8041 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.uri | https://hdl.handle.net/11424/226356 | |
| dc.identifier.wos | WOS:000491295501127 | |
| dc.language.iso | eng | |
| dc.publisher | OXFORD UNIV PRESS | |
| dc.relation.ispartof | ANNALS OF ONCOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial | |
| dc.type | conferenceObject | |
| dspace.entity.type | Publication | |
| oaire.citation.title | ANNALS OF ONCOLOGY | |
| oaire.citation.volume | 30 |
